Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 ...
Recursion Pharmaceuticals jumped by 16.44 percent on Wednesday to close at $6.09 apiece as investors repositioned portfolios ...
Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 26,086 calls trading, 1.1x expected, and implied vol increasing almost 32 ...
Pinker's new book on common knowledge reveals how recursive mentalizing—thinking about thinking—shapes everything from social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback